Chimeric Antigen Receptor (CAR) T-cell Immunotherapy for Hepatocellular Carcinoma: A Review of Current Progress and Challenges. (2025). International Journal of Modern Medicine, 4(06), 1-7. http://www.intjmm.com/index.php/ijmm/article/view/64